The dynamics of granuloma formation in experimental visceral leishmaniasis. - Wikidata - wikimedia - TriplyDB

The dynamics of granuloma formation in experimental visceral leishmaniasis.

The dynamics of granuloma formation in experimental visceral leishmaniasis.

http://www.wikidata.org/entity/Q36357654

about

Zanvil Alexander Cohn 1926-1993 B cell: T cell interactions occur within hepatic granulomas during experimental visceral leishmaniasis Dynamic imaging of experimental Leishmania donovani-induced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8 T cells CD4+ Recent Thymic Emigrants Are Recruited into Granulomas during Leishmania donovani Infection but Have Limited Capacity for Cytokine Production Lessons from other diseases: granulomatous inflammation in leishmaniasis Regulation of immunity during visceral Leishmania infection A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice.Critical roles for LIGHT and its receptors in generating T cell-mediated immunity during Leishmania donovani infection Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells Effector role of blood monocytes in experimental visceral leishmaniasis Immune regulation during chronic visceral leishmaniasis.Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy.Early induction of interleukin-10 limits antigen-specific CD4⁺ T cell expansion, function, and secondary recall responses during persistent phagosomal infection.Tissue granuloma structure-function in experimental visceral leishmaniasis.Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.Balancing immunity and pathology in visceral leishmaniasis.Characterization of protective T cells in the acquired response to Leishmania donovani in genetically determined cure (H-2b) and noncure (H-2d) mouse strains.Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection.Defect in the tissue cellular immune response: experimental visceral leishmaniasis in euthymic C57BL/6 ep/ep mice The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.The Schistosoma mansoni hepatic egg granuloma provides a favorable microenvironment for sustained growth of Leishmania donovani.Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis Immunity and immunosuppression in experimental visceral leishmaniasis.Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model.Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice.Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol.Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani.Leishmaniases of the New World: current concepts and implications for future research Leishmania donovani infection in scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro Bone marrow-derived and resident liver macrophages display unique transcriptomic signatures but similar biological functions.Eosinophils and mast cells in leishmaniasis.Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver.CD4+ T Cells: guardians of the phagosome.Immunotherapy as a strategy for treatment of leishmaniasis: a review of the literature.Immune responses during cutaneous and visceral leishmaniasis.CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice.Leishmania donovani infection initiates T cell-independent chemokine responses, which are subsequently amplified in a T cell-dependent manner.Recombinant interleukin-1 alpha augments granuloma formation and cytokine production but not parasite clearance in mice infected with Leishmania donovani

P2860

Q24680249-800FD782-D50B-4AEB-B8CD-5733D8D916D1 Q27305411-CB69995D-3348-4F86-98C6-69FB41E122C5 Q27315334-2BC37343-118B-45C9-97D1-D2CF6B882C72 Q27321353-E38E69AE-2B50-42DC-8C33-3BA3A9D8C814 Q27323278-8A66098E-AF0B-4E7D-B20A-01ACC1D913D9 Q28066034-90896E47-8BE3-41B2-B5F9-D91F2CCA5F9F Q30452825-D27BA3A3-9CC4-4FFB-B683-33DE901D078D Q31036509-A7D03B00-B46D-4F9E-BB1F-27504BE38AC6 Q33604990-05F195CF-4895-4160-B15E-2E64A9844BDC Q33607724-48059F87-7BD8-48FE-9FE5-581B75BEDD73 Q33619698-52F4F01D-453A-4B4D-946A-6099E6F555E7 Q33881718-58EC528B-6633-4B82-BBC8-F1C46E2F58AE Q34181985-75C59AA7-3D2F-4EF3-AE78-30178C6E2CE0 Q34298717-96892B98-E0BC-43F1-AC9C-616CA4B6E822 Q34434760-A42BB27A-B779-43FF-8B2E-3E6F54332674 Q34570535-DD2AEE9F-14CF-4336-9130-29002E677996 Q34587432-961DCB5C-55CB-4243-9F8F-AB0329BEAD3B Q35102523-493D9C17-4F0B-42F6-9FA5-8409EA3B7AA1 Q35103595-8834660F-7255-4076-B5AE-D3FE4F2D9104 Q35108659-B477A489-4EA4-46AD-BCA5-230D03F08A4D Q35190753-60DA5AF9-7196-47C2-861D-9E4830CF9F6A Q35222060-608E33C7-1ADA-436C-A32E-2C0686F18523 Q35553326-7E5ADA25-11C4-420F-97FA-971B5CF8FB26 Q35738461-ED1259EF-9014-4A4B-9190-F82C59AC2E5D Q36356372-8761C3FB-5DD8-45B7-A05F-F37B6BE55DD6 Q36376855-8CEFE927-BFD7-4435-9542-10B783449066 Q36377093-951F32B0-B833-4F03-AE9D-D44C3224A585 Q36387245-46CCE942-7F52-4B83-A1E3-575CEFE0BA84 Q36421468-4ECA6BDB-4B1C-47BC-A758-9649F14D407A Q36640255-02CA2165-C788-47E1-8178-DF313E56CD05 Q36952431-B5869BA2-8145-470E-90F8-7E4C0FD1018B Q37266172-465D1FC6-52BD-4D52-99EB-39C4BEB07B00 Q37409824-753D8807-5E47-4B49-AAED-F71EEE44623C Q37546954-4405F791-62B0-4175-9B0C-33944271A3EF Q37712789-86104633-C406-4FA4-98B1-61F3FBFE8C75 Q37773297-6347AC30-DD75-484A-854C-C7EAD5E9634B Q38235268-3EE2615D-8035-4451-BD7E-552C7B11D451 Q38868176-1BCCE5C7-F384-4FA4-8E7C-4CE2DB555331 Q38954472-98C1FDDD-3FC7-4272-8D07-28355A55EA42 Q38958188-835959C5-F99C-4E17-948B-426606062255

P2860

The dynamics of granuloma formation in experimental visceral leishmaniasis.

http://www.wikidata.org/entity/Q36357654

description

1988 nî lūn-bûn

@nan

1988年の論文

@ja

1988年学术文章

@wuu

1988年学术文章

@zh-cn

1988年学术文章

@zh-hans

1988年学术文章

@zh-my

1988年学术文章

@zh-sg

1988年學術文章

@yue

1988年學術文章

@zh

1988年學術文章

@zh-hant

name

The dynamics of granuloma formation in experimental visceral leishmaniasis.

@ast

The dynamics of granuloma formation in experimental visceral leishmaniasis.

@en

type

label

The dynamics of granuloma formation in experimental visceral leishmaniasis.

@ast

The dynamics of granuloma formation in experimental visceral leishmaniasis.

@en

prefLabel

The dynamics of granuloma formation in experimental visceral leishmaniasis.

@ast

The dynamics of granuloma formation in experimental visceral leishmaniasis.

@en

P1433

Q36357654-754EDEC0-B89A-42C3-852B-C0F5054AB89F

P1476

Q36357654-FB0307C5-3BC6-494B-8ED4-4CAFA415DC20

P2093

Q36357654-8A91FAD7-A9A1-4884-9386-DE864E94885B

Q36357654-EA542258-3EC7-43DD-8D04-6B4A7CF0E88E

Q36357654-EE21E857-B936-4EC9-8265-DCEC15C6DFF6

P2860

Q36357654-03CEB7C9-C85C-4087-9186-F7EBDE450F3E

Q36357654-18B9A175-CDE0-40F7-860B-AFE8D32D2B6F

Q36357654-1C9E3B05-F38E-4AB1-9BE1-B09C75F01D68

Q36357654-23415854-7056-49A5-810F-98CF2FAED902

Q36357654-4DBE144A-D481-41DD-9799-C5AAAA3E16E5

Q36357654-6C07198A-9CE9-4B5E-919C-D0DC51E16D62

Q36357654-A1AC31A9-E718-4FB8-B234-407A1A275334

Q36357654-A3A3F611-DC2E-49D1-8049-6438740AA4D2

Q36357654-B6D6B796-7A4C-41AE-A276-9BD83977B645

Q36357654-DCF353B0-858F-42E9-8628-CC70145AB5A6

P304

Q36357654-BA36612E-EDF4-499E-BB97-417DFB826E5C

P31

Q36357654-D91A54B6-712A-4957-A580-AE25EDCA65A2

P356

Q36357654-046A5ACB-669B-4822-B5E9-6F9AC9252149

P407

Q36357654-6319BF6A-2400-4E2C-A73F-22A8409F65C1

P433

Q36357654-316154B2-DE5A-41B3-8096-4B2F87F65DEC

P478

Q36357654-35BF155D-004C-4DE9-AD40-37087794A0FA

P577

Q36357654-AABBD4D0-DE99-41F2-9F5F-2509EB424E8A

P5875

Q36357654-B30EEAC3-B1C9-4AE4-B7CA-FF82A4E5063B

P698

Q36357654-85C04985-A702-4F70-A836-3488DD0E76DD

P921

Q36357654-A7694D93-49B0-45A7-8A82-994475704DD2

P932

Q36357654-EE0A0D71-9D99-482E-909A-06B0E014AD58

P356

P1433

Journal of Experimental Medicine

P1476

The dynamics of granuloma formation in experimental visceral leishmaniasis.

@en

P2093

H W Murray

http://www.w3.org/2001/XMLSchema#string

M J McElrath

http://www.w3.org/2001/XMLSchema#string

Z A Cohn

http://www.w3.org/2001/XMLSchema#string

P2860

Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins

F4/80, a monoclonal antibody directed specifically against the mouse macrophage

Regulation of Leishmania populations within the host. II. genetic control of acute susceptibility of mice to Leishmania donovani infection

The cutaneous infiltrates of leprosy. A transmission electron microscopy study.

Liver macrophages in murine listeriosis. Cell-mediated immunity is correlated with an influx of macrophages capable of generating reactive oxygen intermediates.

Cutaneous leishmaniasis. The defect in T cell influx in BALB/c mice.

Mac-1: a macrophage differentiation antigen identified by monoclonal antibody.

Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens.

Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity.

Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages.

P304

1927-1937

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.167.6.1927

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

167

http://www.w3.org/2001/XMLSchema#string

P577

1988-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277522961

http://www.w3.org/2001/XMLSchema#string

P698

3290381

http://www.w3.org/2001/XMLSchema#string

P921

visceral leishmaniasis

P932

2189681

http://www.w3.org/2001/XMLSchema#string